Parkinson's disease-related fatigue: A case definition and recommendations for clinical research.
Identifieur interne : 000242 ( PubMed/Corpus ); précédent : 000241; suivant : 000243Parkinson's disease-related fatigue: A case definition and recommendations for clinical research.
Auteurs : Benzi M. Kluger ; Karen Herlofson ; Kelvin L. Chou ; Jau-Shin Lou ; Christopher G. Goetz ; Anthony E. Lang ; Daniel Weintraub ; Joseph FriedmanSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2016.
Abstract
Fatigue is one of the most common and disabling symptoms in Parkinson's disease (PD). Since fatigue was first described as a common feature of PD 20 years ago, little progress has been made in understanding its causes or treatment. Importantly, PD patients attending the 2013 World Parkinson Congress voted fatigue as the leading symptom in need of further research. In response, the Parkinson Disease Foundation and ProjectSpark assembled an international team of experts to create recommendations for clinical research to advance this field. The working group identified several areas in which shared standards would improve research quality and foster progress including terminology, diagnostic criteria, and measurement. Terminology needs to (1) clearly distinguish fatigue from related phenomena (eg, sleepiness, apathy, depression); (2) differentiate subjective fatigue complaints from objective performance fatigability; and (3) specify domains affected by fatigue and causal factors. We propose diagnostic criteria for PD-related fatigue to guide participant selection for clinical trials and add rigor to mechanistic studies. Recommendations are made for measurement of subjective fatigue complaints, performance fatigability, and neurophysiologic changes. We also suggest areas in which future research is needed to address methodological issues and validate or optimize current practices. Many limitations in current PD-related fatigue research may be addressed by improving methodological standards, many of which are already being successfully applied in clinical fatigue research in other medical conditions (eg, cancer, multiple sclerosis). © 2016 International Parkinson and Movement Disorder Society.
DOI: 10.1002/mds.26511
PubMed: 26879133
Links to Exploration step
pubmed:26879133Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Parkinson's disease-related fatigue: A case definition and recommendations for clinical research.</title><author><name sortKey="Kluger, Benzi M" sort="Kluger, Benzi M" uniqKey="Kluger B" first="Benzi M" last="Kluger">Benzi M. Kluger</name><affiliation><nlm:affiliation>Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Herlofson, Karen" sort="Herlofson, Karen" uniqKey="Herlofson K" first="Karen" last="Herlofson">Karen Herlofson</name><affiliation><nlm:affiliation>Department of Neurology, Sorlandet Hospital Arendal, Norway.</nlm:affiliation></affiliation></author><author><name sortKey="Chou, Kelvin L" sort="Chou, Kelvin L" uniqKey="Chou K" first="Kelvin L" last="Chou">Kelvin L. Chou</name><affiliation><nlm:affiliation>Departments of Neurology and Neurosurgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lou, Jau Shin" sort="Lou, Jau Shin" uniqKey="Lou J" first="Jau-Shin" last="Lou">Jau-Shin Lou</name><affiliation><nlm:affiliation>Department of Neurology, University of North Dakota School of Medicine and Health Science, Department of Neurology, Sanford Health, Fargo, North Dakota, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G" last="Goetz">Christopher G. Goetz</name><affiliation><nlm:affiliation>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name><affiliation><nlm:affiliation>Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Weintraub, Daniel" sort="Weintraub, Daniel" uniqKey="Weintraub D" first="Daniel" last="Weintraub">Daniel Weintraub</name><affiliation><nlm:affiliation>Departments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Friedman, Joseph" sort="Friedman, Joseph" uniqKey="Friedman J" first="Joseph" last="Friedman">Joseph Friedman</name><affiliation><nlm:affiliation>Department of Neurology, Butler Hospital, Alpert Medical School of Brown University, Providence, Rhode Island, USA.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26879133</idno><idno type="pmid">26879133</idno><idno type="doi">10.1002/mds.26511</idno><idno type="wicri:Area/PubMed/Corpus">000242</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000242</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Parkinson's disease-related fatigue: A case definition and recommendations for clinical research.</title><author><name sortKey="Kluger, Benzi M" sort="Kluger, Benzi M" uniqKey="Kluger B" first="Benzi M" last="Kluger">Benzi M. Kluger</name><affiliation><nlm:affiliation>Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Herlofson, Karen" sort="Herlofson, Karen" uniqKey="Herlofson K" first="Karen" last="Herlofson">Karen Herlofson</name><affiliation><nlm:affiliation>Department of Neurology, Sorlandet Hospital Arendal, Norway.</nlm:affiliation></affiliation></author><author><name sortKey="Chou, Kelvin L" sort="Chou, Kelvin L" uniqKey="Chou K" first="Kelvin L" last="Chou">Kelvin L. Chou</name><affiliation><nlm:affiliation>Departments of Neurology and Neurosurgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lou, Jau Shin" sort="Lou, Jau Shin" uniqKey="Lou J" first="Jau-Shin" last="Lou">Jau-Shin Lou</name><affiliation><nlm:affiliation>Department of Neurology, University of North Dakota School of Medicine and Health Science, Department of Neurology, Sanford Health, Fargo, North Dakota, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G" last="Goetz">Christopher G. Goetz</name><affiliation><nlm:affiliation>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name><affiliation><nlm:affiliation>Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Weintraub, Daniel" sort="Weintraub, Daniel" uniqKey="Weintraub D" first="Daniel" last="Weintraub">Daniel Weintraub</name><affiliation><nlm:affiliation>Departments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Friedman, Joseph" sort="Friedman, Joseph" uniqKey="Friedman J" first="Joseph" last="Friedman">Joseph Friedman</name><affiliation><nlm:affiliation>Department of Neurology, Butler Hospital, Alpert Medical School of Brown University, Providence, Rhode Island, USA.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Fatigue is one of the most common and disabling symptoms in Parkinson's disease (PD). Since fatigue was first described as a common feature of PD 20 years ago, little progress has been made in understanding its causes or treatment. Importantly, PD patients attending the 2013 World Parkinson Congress voted fatigue as the leading symptom in need of further research. In response, the Parkinson Disease Foundation and ProjectSpark assembled an international team of experts to create recommendations for clinical research to advance this field. The working group identified several areas in which shared standards would improve research quality and foster progress including terminology, diagnostic criteria, and measurement. Terminology needs to (1) clearly distinguish fatigue from related phenomena (eg, sleepiness, apathy, depression); (2) differentiate subjective fatigue complaints from objective performance fatigability; and (3) specify domains affected by fatigue and causal factors. We propose diagnostic criteria for PD-related fatigue to guide participant selection for clinical trials and add rigor to mechanistic studies. Recommendations are made for measurement of subjective fatigue complaints, performance fatigability, and neurophysiologic changes. We also suggest areas in which future research is needed to address methodological issues and validate or optimize current practices. Many limitations in current PD-related fatigue research may be addressed by improving methodological standards, many of which are already being successfully applied in clinical fatigue research in other medical conditions (eg, cancer, multiple sclerosis). © 2016 International Parkinson and Movement Disorder Society.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">26879133</PMID><DateCreated><Year>2016</Year><Month>05</Month><Day>09</Day></DateCreated><DateRevised><Year>2017</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>May</Month></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov. Disord.</ISOAbbreviation></Journal><ArticleTitle>Parkinson's disease-related fatigue: A case definition and recommendations for clinical research.</ArticleTitle><Pagination><MedlinePgn>625-31</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.26511</ELocationID><Abstract><AbstractText>Fatigue is one of the most common and disabling symptoms in Parkinson's disease (PD). Since fatigue was first described as a common feature of PD 20 years ago, little progress has been made in understanding its causes or treatment. Importantly, PD patients attending the 2013 World Parkinson Congress voted fatigue as the leading symptom in need of further research. In response, the Parkinson Disease Foundation and ProjectSpark assembled an international team of experts to create recommendations for clinical research to advance this field. The working group identified several areas in which shared standards would improve research quality and foster progress including terminology, diagnostic criteria, and measurement. Terminology needs to (1) clearly distinguish fatigue from related phenomena (eg, sleepiness, apathy, depression); (2) differentiate subjective fatigue complaints from objective performance fatigability; and (3) specify domains affected by fatigue and causal factors. We propose diagnostic criteria for PD-related fatigue to guide participant selection for clinical trials and add rigor to mechanistic studies. Recommendations are made for measurement of subjective fatigue complaints, performance fatigability, and neurophysiologic changes. We also suggest areas in which future research is needed to address methodological issues and validate or optimize current practices. Many limitations in current PD-related fatigue research may be addressed by improving methodological standards, many of which are already being successfully applied in clinical fatigue research in other medical conditions (eg, cancer, multiple sclerosis). © 2016 International Parkinson and Movement Disorder Society.</AbstractText><CopyrightInformation>© 2016 International Parkinson and Movement Disorder Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kluger</LastName><ForeName>Benzi M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herlofson</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Sorlandet Hospital Arendal, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chou</LastName><ForeName>Kelvin L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Departments of Neurology and Neurosurgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lou</LastName><ForeName>Jau-Shin</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of North Dakota School of Medicine and Health Science, Department of Neurology, Sanford Health, Fargo, North Dakota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goetz</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>Anthony E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weintraub</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Departments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Butler Hospital, Alpert Medical School of Brown University, Providence, Rhode Island, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K02 NS080885</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 NS091856</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Phys Med Rehabil Clin N Am. 2009 May;20(2):325-37</RefSource><PMID Version="1">19389614</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2014 Jul 15;83(3):215-20</RefSource><PMID Version="1">24928125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Neurol Scand. 2015 Feb;131(2):80-7</RefSource><PMID Version="1">25288130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychology. 2010 Jan;24(1):77-83</RefSource><PMID Version="1">20063948</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2003 Oct;18(10):1108-14</RefSource><PMID Version="1">14534913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2009 Jul 30;24(10):1481-7</RefSource><PMID Version="1">19441128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 2002 Dec 13;957(2):320-9</RefSource><PMID Version="1">12445974</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2005 Jan;11(1):49-55</RefSource><PMID Version="1">15619463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Physiol Rev. 2001 Oct;81(4):1725-89</RefSource><PMID Version="1">11581501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am Rev Respir Dis. 1988 Aug;138(2):266-71</RefSource><PMID Version="1">3195826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 1994 Dec 15;121(12):953-9</RefSource><PMID Version="1">7978722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2007 Jan 30;68(5):384-6</RefSource><PMID Version="1">17082464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2010 Nov;133(11):3434-43</RefSource><PMID Version="1">20884645</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2008 Aug 12;71(7):481-5</RefSource><PMID Version="1">18695158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2013 Mar;19(3):335-8</RefSource><PMID Version="1">23246138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2014 Sep 16;83(12):1096-103</RefSource><PMID Version="1">25128183</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2010 May 15;25(7):805-22</RefSource><PMID Version="1">20461797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2007 Feb 15;22(3):297-308</RefSource><PMID Version="1">17133511</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 1994 Jan;18 Suppl 1:S79-83</RefSource><PMID Version="1">8148458</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2013 Feb;19(2):148-52</RefSource><PMID Version="1">23107555</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Psychosom Res. 1995 Apr;39(3):315-25</RefSource><PMID Version="1">7636775</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2013 Jan 22;80(4):409-16</RefSource><PMID Version="1">23339207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Phys Med Rehabil Clin N Am. 2012 Feb;23(1):11-22, ix</RefSource><PMID Version="1">22239870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(10):e47387</RefSource><PMID Version="1">23082161</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2004 Nov 23;63(10):1908-11</RefSource><PMID Version="1">15557510</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurorehabil Neural Repair. 2012 Jun;26(5):533-41</RefSource><PMID Version="1">22140196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Cogn. 2014 Mar;85:251-8</RefSource><PMID Version="1">24486386</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drugs Aging. 2009;26(3):195-208</RefSource><PMID Version="1">19358616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Popul Health Metr. 2009 Dec 15;7:18</RefSource><PMID Version="1">20003524</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2005 Sep;11(6):353-61</RefSource><PMID Version="1">16105745</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Sci. 2009 Jun 15;281(1-2):46-50</RefSource><PMID Version="1">19303081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Behav Neurol. 2000;12(3):103-6</RefSource><PMID Version="1">11455047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Disabil Rehabil. 2007 Dec 30;29(24):1934-6</RefSource><PMID Version="1">17852221</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2014 Nov;29(13):1675-8</RefSource><PMID Version="1">25234443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014;9(4):e94222</RefSource><PMID Version="1">24705397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2001 Mar;16(2):190-6</RefSource><PMID Version="1">11295769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2013 Oct 2;105(19):1432-40</RefSource><PMID Version="1">24047960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2008 May;44(8):1097-104</RefSource><PMID Version="1">18381237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mult Scler. 2010 Jun;16(6):724-32</RefSource><PMID Version="1">20375125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 2014 May 2;1561:60-6</RefSource><PMID Version="1">24642273</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroscience. 2014 Mar 7;261:60-7</RefSource><PMID Version="1">24388922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2011 Mar;26(4):644-52</RefSource><PMID Version="1">21312275</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Brain Res. 2012 Feb;216(4):585-90</RefSource><PMID Version="1">22130780</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2009 Jun 15;24(8):1211-6</RefSource><PMID Version="1">19412942</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2015 Feb;30(2):229-37</RefSource><PMID Version="1">25449044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Sleep Res. 2007 Mar;16(1):102-9</RefSource><PMID Version="1">17309769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2011 Aug 15;26(10):1869-74</RefSource><PMID Version="1">21542023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arthritis Rheum. 2010 Jun;62(6):1829-36</RefSource><PMID Version="1">20191578</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 1989 Oct;46(10):1121-3</RefSource><PMID Version="1">2803071</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2007 Jun 15;22(8):1077-92</RefSource><PMID Version="1">17394234</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neural Transm Park Dis Dement Sect. 1993;5(3):235-44</RefSource><PMID Version="1">8369103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(10):e77914</RefSource><PMID Version="1">24167590</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Neurol. 2010 Dec;17(12):1428-36</RefSource><PMID Version="1">20491889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mult Scler. 2009 Mar;15(3):337-44</RefSource><PMID Version="1">18987107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2008 Jan 3;358(1):55-68</RefSource><PMID Version="1">18172175</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Behav Neurol. 2001-2002;13(3-4):117-21</RefSource><PMID Version="1">12446951</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 2013 Sep 5;1529:105-12</RefSource><PMID Version="1">23880373</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PM R. 2010 May;2(5):406-13</RefSource><PMID Version="1">20656622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1987 Jan 30;235(4788):580-5</RefSource><PMID Version="1">3810158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2013 Nov;19(11):966-9</RefSource><PMID Version="1">23849499</PMID></CommentsCorrections></CommentsCorrectionsList><OtherID Source="NLM">NIHMS741216 [Available on 05/01/17]</OtherID><OtherID Source="NLM">PMC4863238 [Available on 05/01/17]</OtherID><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Parkinson's disease</Keyword><Keyword MajorTopicYN="N">case definition</Keyword><Keyword MajorTopicYN="N">clinical research</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>08</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>11</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26879133</ArticleId><ArticleId IdType="doi">10.1002/mds.26511</ArticleId><ArticleId IdType="pmc">PMC4863238</ArticleId><ArticleId IdType="mid">NIHMS741216</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000242 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000242 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:26879133
|texte= Parkinson's disease-related fatigue: A case definition and recommendations for clinical research.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26879133" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |